Cargando…

Prognostic value of serum high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study

BACKGROUND: We compared the prognostic value of serum high mobility group box 1 protein (HMGB1) and histone H3 levels with the International Society on Thrombosis and Haemostasis (ISTH) disseminated intravascular coagulation (DIC) scores for 28-day in-hospital mortality in patients with DIC caused b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Hirotaka, Kataoka, Yuki, Harada-Shirado, Kayo, Kawano, Noriaki, Hayakawa, Mineji, Seki, Yoshinobu, Uchiyama, Toshimasa, Yamakawa, Kazuma, Ishikura, Hiroyasu, Irie, Yuhei, Nishio, Kenji, Yada, Noritaka, Okamoto, Kohji, Yamada, Shingo, Ikezoe, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190102/ https://www.ncbi.nlm.nih.gov/pubmed/35698137 http://dx.doi.org/10.1186/s12959-022-00390-2

Ejemplares similares

Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on Thrombosis and Haemostasis: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2023)

Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study
por: Mori, Hirotaka, et al.
Publicado: (2022)

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure
por: Kawano, Noriaki, et al.
Publicado: (2020)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
por: Kawasugi, Kazuo, et al.
Publicado: (2021)

Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment—A Cohort Study Using a Postmarketing Surveillance Database
por: Yoshinobu, Seki, et al.
Publicado: (2021)

Optimal Timing and Early Intervention With Anticoagulant Therapy for Sepsis-Induced Disseminated Intravascular Coagulation
por: Yamakawa, Kazuma, et al.
Publicado: (2019)

Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study
por: Umemura, Yutaka, et al.
Publicado: (2018)

Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis
por: Wada, Hideo, et al.
Publicado: (2020)

Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
por: Wada, Hideo, et al.
Publicado: (2023)

New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study
por: Ishikura, Hiroyasu, et al.
Publicado: (2014)

Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011–2013
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Sepsis‐induced disseminated intravascular coagulation: an international estrangement of disease concept
por: Ushio, Noritaka, et al.
Publicado: (2023)

A summary of the Japan septic disseminated intravascular coagulation study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

The Treatment Intensity of Anticoagulant Therapy for Patients With Sepsis-Induced Disseminated Intravascular Coagulation and Outcomes: A Multicenter Cohort Study
por: Kudo, Daisuke, et al.
Publicado: (2019)

Validating plasminogen activator inhibitor‐1 as a poor prognostic factor in sepsis
por: Hoshino, Kota, et al.
Publicado: (2020)

Interventional radiology versus operative management for splenic injuries: a study protocol for a systematic review and meta-analysis
por: Kashiura, Masahiro, et al.
Publicado: (2019)

Emergency administration of fibrinogen concentrate for hemorrhage: A protocol for systematic review and meta-analysis
por: Itagaki, Yuki, et al.
Publicado: (2021)

Usefulness of plasminogen activator inhibitor-1 as a predictive marker of mortality in sepsis
por: Hoshino, Kota, et al.
Publicado: (2017)

Glial fibrillary acidic protein level on admission can predict severe traumatic brain injury in patients with severe multiple trauma: A single-center retrospective observational study
por: Nakamura, Yoshihiko, et al.
Publicado: (2022)

Emergency administration of fibrinogen concentrate for haemorrhage: systematic review and meta-analysis
por: Itagaki, Yuki, et al.
Publicado: (2023)

Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study
por: Nakamura, Yoshihiko, et al.
Publicado: (2017)

Changes in Mannose-Binding Lectin and Collectin Kidney 1 Levels in Sepsis Patients With and Without Disseminated Intravascular Coagulation
por: Hayakawa, Mineji, et al.
Publicado: (2019)

Special Issue on “Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives”
por: Yamakawa, Kazuma
Publicado: (2022)

Real‐world evidence on disseminated intravascular coagulation from Japan
por: Hisamune, Ryo, et al.
Publicado: (2023)

Activated protein C does not increase in the early phase of trauma with disseminated intravascular coagulation: comparison with acute coagulopathy of trauma-shock
por: Jesmin, Subrina, et al.
Publicado: (2016)

Disseminated intravascular coagulation with the fibrinolytic phenotype predicts the outcome of patients with out-of-hospital cardiac arrest
por: Wada, Takeshi, et al.
Publicado: (2016)

Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury
por: Wada, Takeshi, et al.
Publicado: (2017)

Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review
por: Mori, Hirotaka, et al.
Publicado: (2021)

Oral Health of COVID-19 Patients Using Extracorporeal Membrane Oxygenation: A Clinical Study of 19 Cases
por: Yoshino, Aya, et al.
Publicado: (2021)

Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation
por: Ikezoe, Takayuki
Publicado: (2015)

Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
por: Kudo, Daisuke, et al.
Publicado: (2021)

Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
por: Goto, Tadahiro, et al.
Publicado: (2022)

Anticoagulant therapies against sepsis‐induced disseminated intravascular coagulation
por: Umemura, Yutaka, et al.
Publicado: (2023)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
por: Yamakawa, Kazuma, et al.
Publicado: (2016)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aulqo7dohn9g43odu8oo15kha8